Keppra 100 mg/ml (Levetiracetam)

Keppra 100 mg/ml Oral Solution - Levetiracetam by UCB

Active ingredient: Levetiracetam 100 mg/ml
Dosage form: Oral solution
Volume: 300 ml bottle
Route: Oral use (with included 10 ml syringe)
Approved age: Adults and children 4 years and older
Manufacturer: UCB Pharma

Product description

Keppra contains levetiracetam - one of the most prescribed modern antiepileptics worldwide. Unlike older anticonvulsants, it acts via binding to SV2A synaptic protein, modulating neurotransmitter release without affecting normal neuronal function - which explains its favorable tolerability profile and minimal drug interactions.

The oral solution format allows precise weight-based dosing for children (4+ years) and adults who cannot swallow tablets. Original product by UCB - the developer of the molecule.

Indications

• focal (partial) epilepsy with or without secondary generalization - monotherapy or adjunctive therapy;
• generalized tonic-clonic seizures - adjunctive therapy;
• myoclonic seizures in juvenile myoclonic epilepsy - adjunctive therapy;
• as prescribed by a neurologist.

Dosage and administration

Dosing is weight-based, especially in children, and set strictly by the physician. The oral solution allows exact dose measurement with the included 10 ml syringe (marked in mg). Doses are taken twice daily, with or without food. Do not stop abruptly - gradual withdrawal under medical supervision only.

Typical adult maintenance dose: 1500 mg twice daily (as per approved protocols); pediatric dosing starts lower and titrates by weight. Follow your prescription exactly.

Contraindications

• hypersensitivity to levetiracetam or any excipient;
• disclose all medicines to the physician - dose adjustment may be needed with renal impairment;
• pregnancy/breastfeeding - only if clearly needed, per physician decision.

Safety notes

Common side effects in the first weeks: drowsiness, dizziness, weakness - usually transient. Rare but serious: behavioral changes, mood alterations - report immediately to the physician. Do not discontinue abruptly (risk of seizures).

Storage conditions

Store at a temperature not exceeding 25 °C, do not freeze. Keep out of reach of children. Use the solution within the period indicated after first opening (see leaflet).

FAQ

Is Keppra used only for epilepsy?

Yes - levetiracetam is approved for epilepsy (focal, generalized tonic-clonic, myoclonic seizures). Any other use is decided solely by the treating physician.

Why the oral solution instead of tablets?

The solution allows exact weight-based dosing (essential in children 4+ years) and suits patients who cannot swallow tablets. Dose is measured with the included syringe.

Does Keppra cause sedation?

Drowsiness in the first weeks is common but usually transient. Compared to older anticonvulsants, levetiracetam has a favorable cognitive profile.

Can Keppra be combined with other antiepileptics?

Often yes - levetiracetam has minimal drug interactions (one of its advantages). The combination is decided by the neurologist.

Can I stop taking it abruptly?

No. Abrupt discontinuation can trigger seizures - withdrawal is always gradual under medical supervision.

Ask a question or inquire about delivery to your country

Telegram

WhatsApp